Direct renin inhibitors as antihypertensive drugs
This presentation is the property of its rightful owner.
Sponsored Links
1 / 66

DIRECT RENIN INHIBITORS AS ANTIHYPERTENSIVE DRUGS PowerPoint PPT Presentation


  • 102 Views
  • Uploaded on
  • Presentation posted in: General

www.pharmaxchange.info. DIRECT RENIN INHIBITORS AS ANTIHYPERTENSIVE DRUGS. DATE – OCTOBER 23 rd , 2009 PRESENTED BY – AKUL MEHTA VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF PHARMACY DEPARTMENT OF MEDICINAL CHEMISTRY. www.pharmaxchange.info. WHAT IS HYPERTENSION?.

Download Presentation

DIRECT RENIN INHIBITORS AS ANTIHYPERTENSIVE DRUGS

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Direct renin inhibitors as antihypertensive drugs

www.pharmaxchange.info

DIRECT RENIN INHIBITORS AS ANTIHYPERTENSIVE DRUGS

DATE – OCTOBER 23rd, 2009

PRESENTED BY – AKUL MEHTA

VIRGINIA COMMONWEALTH UNIVERSITYSCHOOL OF PHARMACY

DEPARTMENT OF MEDICINAL CHEMISTRY


What is hypertension

www.pharmaxchange.info

WHAT IS HYPERTENSION?

  • Normal Blood Pressure = 120/80

    • Systolic = 90 – 119 mm Hg

    • Diastolic = 60 – 79 mm Hg

  • Hypertension = High Blood Pressure

  • Known risk factor of several Cardiovascular Disorders

Chobanian, A. V. et al.Hypertension2003,42, 1206-1252


Renin angiotensin system

www.pharmaxchange.info

RENIN ANGIOTENSIN SYSTEM

  • AngI = Angiotensin I

  • ACE = Angiotensin converting enzyme

  • AngII = Angiotensin II

Image adapted from - Li, Y. C. Curr. Opin. Invest. Drugs 2007, 8, 750-757.


Current drugs targeting the renin angiotensin system for hypertension

www.pharmaxchange.info

CURRENT DRUGS TARGETING THE RENIN-ANGIOTENSIN SYSTEM FOR HYPERTENSION

IS THERE REALLY A NEED FOR ANOTHER ANTIHYPERTENSIVE

DRUG?


Need for another antihypertensive

www.pharmaxchange.info

NEED FOR ANOTHER ANTIHYPERTENSIVE

  • Hypertension needs modulation

Li, Y. C. Curr. Opin. Invest. Drugs 2007, 8, 750-757.

Image from - http://blog.wineenthusiast.com/wp-content/uploads/2008/12/balance.jpg


Need for another antihypertensive1

www.pharmaxchange.info

NEED FOR ANOTHER ANTIHYPERTENSIVE

  • Limitations of current drugs targeting the system

Li, Y. C. Curr. Opin. Invest. Drugs 2007, 8, 750-757.


Need for another antihypertensive2

www.pharmaxchange.info

NEED FOR ANOTHER ANTIHYPERTENSIVE

  • Hypertension  1° risk factor in cardiovascular diseases

  • Worldwide prevalance of ≈ 1 billion people (almost 1/6th of the human population)

  • United States of America > 60 million people

  • < 30% of patients achieve treatment goals

IS THERE REALLY A NEED FOR ANOTHER ANTIHYPERTENSIVE

DRUG?

YES THERE IS DEFINITELY A NEED

Yokokawa, F. et al. Expert Opin. Ther. Patents 2008,18(6), 581-602.


Current interest in inhibition of renin angiotensin system

www.pharmaxchange.info

CURRENT INTEREST IN INHIBITION OF RENIN ANGIOTENSIN SYSTEM

Yokokawa, F. et al.Expert Opin. Ther. Patents 2008,18(6), 581-602.


Introducing renin

www.pharmaxchange.info

INTRODUCING RENIN

  • History

  • Structure

  • Function

  • Mechanism

PDB ID – 2v0z


Renin history

www.pharmaxchange.info

RENIN - HISTORY

  • 1898- Tigerstedt and Bergman

    • Kidney extracts produce pressor effects- coined the term ‘renin’

Phillips, M. I. News Physiol. Sci. 1999,14, 271-274


Renin history1

www.pharmaxchange.info

RENIN - HISTORY

  • 1934- Harry Goldblatt

    • Induced experimental hypertension in dogs

    • 1st to prove that renin system blockade would reduce hypertension

Basso, N. et al. Hypertension2001,38, 1246-1249.


Renin history2

www.pharmaxchange.info

RENIN - HISTORY

  • 1970- Tadashi Inigami

    • Isolated pure renin from hog kidney

    • This was followed by isolation from rat and human kidney.

  • Currently working Vanderbilt University School of Medicine


Renin structure

www.pharmaxchange.info

RENIN - STRUCTURE

  • Highly Species Specific

  • 340 amino acids

  • Two beta pleated sheets make two lobes

  • Active site between the two lobes

  • Aspartates for the active site provided by each lobe – i.e. Asp 32 and Asp. 215

ASP32

ASP215

Eder, J. et al. Current Pharmaceutical Design, 2007,13, 271-285.

PDB ID- 2v0z


Renin function

www.pharmaxchange.info

RENIN - FUNCTION

Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu10--Val11-Ile-His-Asn---

Angiotensinogen (480 amino acid long)

Renin cleaves peptide bond

between Leu10-Val11

Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu10 + Val11-Ile-His-Asn---

Angiotensin I


Renin mechanism

www.pharmaxchange.info

RENIN - MECHANISM

ENZYME

ACTIVE SITE

Eder, J. et al. Current Pharmaceutical Design, 2007,13, 271-285.


How does one measure renin inhibition

www.pharmaxchange.info

HOW DOES ONE MEASURE RENIN INHIBITION?

  • In Vitro

    • Human renin is incubated with inhibitor

    • Angiotensinogen is added.

    • Angiotensin I produced is measured by radioimmunoassay

  • In Vivo

    • Animal testing was done on sodium depleted marmosets

    • Now even transgenic rats are used

    • Changes in blood pressure and heart rate is measured telemetrically.

Image from - http://www.bukisa.com/articles/50597_marmoset-monkeys-and-their-habitats


Inhibitors of renin

www.pharmaxchange.info

INHIBITORS OF RENIN


Inhibitors of renin1

www.pharmaxchange.info

INHIBITORS OF RENIN

  • Early Inhibitors of Renin

    • Antibodies

  • Transition State Analogs

    • Peptide Mimetic Inhibitors

    • Non-Peptide Inhibitors

      • Recently developed Inhibitors


Inhibitors of renin2

www.pharmaxchange.info

INHIBITORS OF RENIN

  • Early Inhibitors of Renin

    • Antibodies

  • Transition State Analogs

    • Peptide Mimetic Inhibitors

    • Non-Peptide Inhibitors

      • Recently developed Inhibitors


Early inhibitors of renin

www.pharmaxchange.info

EARLY INHIBITORS OF RENIN

  • Monoclonal Antibodies Against Renin

    • Excellent tools to study enzyme and its hypertensive effects

    • However –

      • parenteral administration

      • immunogenecitytherefore less application in medicine.

Galen, F. X. J. Clin. Invest. 1984,74, 723-735.


Inhibitors of renin3

www.pharmaxchange.info

INHIBITORS OF RENIN

  • Early Inhibitors of Renin

    • Antibodies

  • Transition State Analogs

    • Peptide Mimetic Inhibitors

    • Non-Peptide Inhibitors

      • Recently developed Inhibitors


Schechter and berger nomenclature for proteases

www.pharmaxchange.info

SCHECHTER AND BERGER NOMENCLATURE FOR PROTEASES

Mitti, P. R. Curr. Opin. Struct. Biol.2006, 16, 769-775.


Theory of transition state analogs

www.pharmaxchange.info

THEORY OF TRANSITION STATE ANALOGS

Transition

State

I

Enzyme Active Site

Inhibitor with

structure

similar to

transition state

will have high

affinity.

Energy

Product

Substrate

Reaction Co-ordinate

Schramm, V. L. Annu. Rev. Biochem. 1998,67, 693-720.


Peptide mimetic inhibitors

www.pharmaxchange.info

PEPTIDE MIMETIC INHIBITORS

  • Modification of scissile bond with statine and its variants

    Normal Substrate: Angiotensinogen

    Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn-]

    Statine Analog:

    Boc-Phe-His-Stat-Leu-Phe-NH2

Normal Peptide

IC50 – 190nM

Boger, J. et al. J. Med. Chem. 1985,28, 1779-1790.


Peptide mimetic inhibitors1

www.pharmaxchange.info

PEPTIDE MIMETIC INHIBITORS

Statine Analog:

Boc-Phe-His-Stat-Leu-Phe-NH2

ACHPA Analog:

Boc-Phe-His-ACHPA-Leu-Phe-NH2

IC50 – 49nM


Non peptide inhibitors of renin

www.pharmaxchange.info

NON-PEPTIDE INHIBITORS OF RENIN

  • STORY OF ALISKIREN (DEVELOPED BY NOVARTIS)

  • DEVELOPMENT OF PIPERIDINE CLASS OF RENIN INHIBITORS (DEVELOPED BY HOFFMAN LA ROCHE AND OTHERS)


Non peptide inhibitors of renin story of aliskiren

www.pharmaxchange.info

NON-PEPTIDE INHIBITORS OF RENINSTORY OF ALISKIREN


Story of aliskiren

www.pharmaxchange.info

STORY OF ALISKIREN

Boc-Phe-His-ACHPA-Leu-Phe-NH2

CGP38560

IC50 = 1nM

  • The Renin-Angiotensin System; Robertson, J. I. S., Nicholls, M. G., Eds.; Mosby: London, 1993.


Story of aliskiren1

www.pharmaxchange.info

STORY OF ALISKIREN

CGP38560

S1

S3

IC50 = 1nM

S3

S1

Goshke, R. et al. Bioorg. Med. Chem. Lett.1997, 7, 2735-2740.


Story of aliskiren2

www.pharmaxchange.info

STORY OF ALISKIREN

Can be changed to methyl

-OCH2COOCH3 > -OCH2CONH2 > -OCH2COOH

-isopropyl was found optimum

Increase or decrease in substituent size caused decrease in activity

S1

S3

-phenyl substituent

equipotent to -t-butyl

R-epimer showed significant drop in activity


Story of aliskiren3

www.pharmaxchange.info

STORY OF ALISKIREN

Most IC50 in μM range

IC50 = 20nM


Story of aliskiren4

www.pharmaxchange.info

STORY OF ALISKIREN

To improve physicochemical properties


Story of aliskiren5

www.pharmaxchange.info

STORY OF ALISKIREN

When R2 = -CH2CONH2

R3= -Me

R4= -n-butyl

Goshke, R. et al. J. Med. Chem. 2007, 50, 4818-4831.


Story of aliskiren6

www.pharmaxchange.info

STORY OF ALISKIREN


Story of aliskiren7

www.pharmaxchange.info

STORY OF ALISKIREN

Maibaum, J. et. al. J. Med. Chem. 2007,50, 4832-4844.


Story of aliskiren8

www.pharmaxchange.info

STORY OF ALISKIREN


Story of aliskiren9

www.pharmaxchange.info

STORY OF ALISKIREN

Aliskiren

Green= CGP38560

Purple= Aliskiren

Wood, J. M. et al. Biochem. Biophys. Res. Comm. 2003,308, 698-705.

PDB ID – 2v0z


Summary of aliskiren

www.pharmaxchange.info

SUMMARY OF ALISKIREN

CGP38560

Aliskiren


Non peptide inhibitors of renin piperidine class of inhibitors

www.pharmaxchange.info

NON-PEPTIDE INHIBITORS OF RENIN-PIPERIDINE CLASS OF INHIBITORS


Direct renin inhibitors as antihypertensive drugs

PIPERIDINE CLASS OF INHIBITORS

www.pharmaxchange.info

Screening of the Roche Compound Library

IC50 = 50 μM

Highly selective for

renin.

Vieira, E. et al. Bioorg. Med. Chem. Lett. 1999, 9, 1397-1402.


Direct renin inhibitors as antihypertensive drugs

PIPERIDINE CLASS OF INHIBITORS

www.pharmaxchange.info

  • X-Ray Structure Interpretation

Asp32-COOH

HOOC-Asp215

S4

S3

S1


Piperidine class of inhibitors

www.pharmaxchange.info

PIPERIDINE CLASS OF INHIBITORS

S4

S3

S1


Piperidine class of inhibitors1

www.pharmaxchange.info

PIPERIDINE CLASS OF INHIBITORS

  • X-Ray Analysis

Asp32-COOH

HOOC-Asp215

Asp32-COOH

HOOC-Asp215

S3sp

S4

S1

S3

Lifts a whole flap region

fromThr72 to Ser81

S3

S1


Direct renin inhibitors as antihypertensive drugs

PIPERIDINE CLASS OF INHIBITORS

www.pharmaxchange.info

* Indicates point of attachment

to piperidine ring

S3sp

S3

S1

Guller, R. et al. Bioorg. Med. Chem. Lett. 1999, 9, 1403-1408.


Direct renin inhibitors as antihypertensive drugs

PIPERIDINE CLASS OF INHIBITORS

www.pharmaxchange.info

S3sp

S1

S3

Story for these molecules in literature ends here

Marki, H. P. et al. Il Farmaco2001, 56, 21-27.


Piperidine class of inhibitors ketopiperazines

www.pharmaxchange.info

PIPERIDINE CLASS OF INHIBITORS-KETOPIPERAZINES

IC50 = 2nM

IC50 = 180nM

IC50 = 54nM

SAR studies

Holsworth, D. D. et al.Bioorg. Med. Chem.2005, 13, 2657-2664.


Piperidine class of inhibitors ketopiperazines1

www.pharmaxchange.info

PIPERIDINE CLASS OF INHIBITORS-KETOPIPERAZINES

S3sp

S3

S1

Found to inhibit CYP3A4

* Indicates point of attachment to O.


Piperidine class of inhibitors ketopyrazines

www.pharmaxchange.info

PIPERIDINE CLASS OF INHIBITORS-KETOPYRAZINES

S3sp

S3

S1

* Indicates point of attachment to N of tetrahydroquinoline

* Indicates point of attachment to N of tetrahydroquinoline

Holsworth, D. D. et al. Bioorg. Med. Chem. Lett. 2006, 16, 2500-2504.


Piperidine class of inhibitors ketopiperazines2

www.pharmaxchange.info

PIPERIDINE CLASS OF INHIBITORS-KETOPIPERAZINES

S3sp

S3

S1

* Indicates point of attachment to N of tetrahydroquinoline

* Indicates point of attachment to N of tetrahydroquinoline

Holsworth, D. D. et al.Bioorg. Med. Chem. Lett. 2006, 16, 2500-2504.


Piperidine class of inhibitors ketopiperazines3

www.pharmaxchange.info

PIPERIDINE CLASS OF INHIBITORS-KETOPIPERAZINES

Tyr14

Tyr 14

H2O

Crystal Structure

Schematic View

Holsworth, D. D. et al. Bioorg. Med. Chem. Lett. 2006, 16, 2500-2504.

PDB ID – 2fs4


Piperidine class of inhibitors ketopiperazines4

www.pharmaxchange.info

PIPERIDINE CLASS OF INHIBITORS-KETOPIPERAZINES

S3sp

S3

S1

* Indicates point of attachment to C of Methyl


Summary of piperidine class

www.pharmaxchange.info

SUMMARY OF PIPERIDINE CLASS


Recently developed inhibitors of renin

www.pharmaxchange.info

RECENTLY DEVELOPED INHIBITORS OF RENIN

  • 3,9-diazobicyclo [3.3.1] nonene derivatives

Displaces H2O

from active site

aspartates

Bezencon, O. et al. J. Med. Chem. 2009, 52, 3689-3702.


Recently developed inhibitors of renin1

www.pharmaxchange.info

RECENTLY DEVELOPED INHIBITORS OF RENIN

  • 3,9-diazobicyclo [3.3.1] nonene derivatives

-H, -CH3, -cyclopropane

  • short linker preferred

  • ortho, meta substituents

  • improve

  • affinity.

  • ortho di-halo substituents preferred

  • 4-methyl group preferred

IC50 (nM) IC50 (nM)

Rec. Renin= 0.20 Plasma Renin= 19

Bezencon, O. et al. J. Med. Chem. 2009, 52, 3689-3702.


Recently developed inhibitors of renin2

www.pharmaxchange.info

RECENTLY DEVELOPED INHIBITORS OF RENIN

  • Alkyl amines

S3sp

HOOC-Asp32

HOOC-Asp215

S1

S3

Tice, C. M. et al. Bioorg. Med. Chem. Lett.2009, 19, 3541-3545.


Recently developed inhibitors of renin3

www.pharmaxchange.info

RECENTLY DEVELOPED INHIBITORS OF RENIN

  • Alkyl amines

3o alcohol would interact with Ser 219 γ Oxygen

-Me > -H

-Me> -Et

3-Cl > 3-F > 2-Cl > 2,3-diCl

Human Renin = 0.47 nM

Plasma Renin = 13 nM

Oral Bioavailability = 38%

(in dog)

Tice, C. M. et al. Bioorg. Med. Chem. Lett.2009, 19, 3541-3545.


Recently developed inhibitors of renin4

www.pharmaxchange.info

RECENTLY DEVELOPED INHIBITORS OF RENIN

  • Orally bioavailable alkyl amines- crystal structure

Tice, C. M. et al. Bioorg. Med. Chem. Lett.2009, 19, 3541-3545.

PDB ID = 3gw5


Future target of the renin angiotensin system

www.pharmaxchange.info

FUTURE TARGET OF THE RENIN-ANGIOTENSIN SYSTEM


Future target of renin angiotensin system

www.pharmaxchange.info

FUTURE TARGET OF RENIN ANGIOTENSIN SYSTEM

Involvement of Renin-Angiotensin System

  • Clearly not mediated

  • by Ang II.

  • Is there a

  • Renin Receptor?

Nguyen, G. et al. Curr. Opin. Nephrol. Hypertens. 2003, 12, 51-55.


Future target of renin angiotensin system1

www.pharmaxchange.info

FUTURE TARGET OF RENIN ANGIOTENSIN SYSTEM

Nguyen, G. et al. Journ. Clin. Invest. 2002, 109, 1417-1427

Image adapted from- http://tainano.com/Molecular%20Biology%20Glossary.files/image087.gif


Future target of renin angiotensin system2

www.pharmaxchange.info

FUTURE TARGET OF RENIN ANGIOTENSIN SYSTEM

  • Functionality of the receptor

    • Effect on Ang I generation in presence of renin

Membrane bound renin 1nM

Free renin 1nM

Membrane bound renin 0.5nM

Free renin 0.5nM

Agen = Angiotensinogen

Ang I = Angiotensin I


Future target of renin angiotensin system3

www.pharmaxchange.info

FUTURE TARGET OF RENIN ANGIOTENSIN SYSTEM

  • Functionality of the receptor

    • Effect on ERK1/ERK2 activation


Future target of renin angiotensin system4

www.pharmaxchange.info

FUTURE TARGET OF RENIN ANGIOTENSIN SYSTEM

  • Coronary

  • Artery

  • Immunofluorescence studies of receptors on cells of human:

    • Kidney

    • Placenta


Future target of renin angiotensin system5

www.pharmaxchange.info

FUTURE TARGET OF RENIN ANGIOTENSIN SYSTEM

  • Characteristics of renin receptor:

    • 350 amino-acid protein with no homology

    • 45-kDa

    • Multidomain

      • Hydrophobic amino-terminal domainbinds renin and prorenin  activates it

      • Cytoplasmic tail= 20 amino acids  activates ERK1/ERK2 intracellularly

      • Single transmembrane domain

Campbell, D. J. Hypertension, 2008, 51, 1259-1264.


Conclusion

www.pharmaxchange.info

CONCLUSION

Over 100 years since discovery of renin


Acknowledgements

www.pharmaxchange.info

ACKNOWLEDGEMENTS

  • Dr. Umesh Desai

  • The Desai Group

  • Department of Medicinal Chemistry at VCU


  • Login